Karl Weiss

2.2k total citations · 1 hit paper
37 papers, 1.5k citations indexed

About

Karl Weiss is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Karl Weiss has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 21 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Karl Weiss's work include Clostridium difficile and Clostridium perfringens research (12 papers), Microscopic Colitis (8 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Karl Weiss is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (12 papers), Microscopic Colitis (8 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Karl Weiss collaborates with scholars based in Canada, Germany and United States. Karl Weiss's co-authors include Sherwood L. Gorbach, Oliver A. Cornely, Roberto Esposito, Derrick W. Crook, P.S. Sears, Michael Somero, André Poirier, Isabelle Mohr, Michel Savoie and Thomas Louie and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Clinical Infectious Diseases.

In The Last Decade

Karl Weiss

34 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial

2012 560 citations Oliver A. Cornely, Derrick W. Crook et al. The Lancet Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karl Weiss Canada	18	1.1k	948	388	203	198	37	1.5k
Anne J Gonzales-Luna United States	16	969 0.9×	631 0.7×	310 0.8×	306 1.5×	200 1.0×	64	1.2k
Y Arabi United Kingdom	20	765 0.7×	517 0.5×	696 1.8×	172 0.8×	104 0.5×	32	1.7k
Jacques Tankovic France	26	522 0.5×	653 0.7×	575 1.5×	468 2.3×	136 0.7×	57	2.1k
David W. Hecht United States	22	878 0.8×	545 0.6×	263 0.7×	280 1.4×	47 0.2×	41	1.6k
R Y Kwok United States	11	1.4k 1.2×	866 0.9×	183 0.5×	110 0.5×	121 0.6×	16	1.5k
Matthew Oughton Canada	11	2.2k 2.0×	1.6k 1.7×	481 1.2×	211 1.0×	199 1.0×	21	2.5k
T.-W. Chang United States	14	1.8k 1.6×	942 1.0×	272 0.7×	319 1.6×	233 1.2×	30	2.2k
Scott Curry United States	13	2.0k 1.7×	1.4k 1.5×	445 1.1×	317 1.6×	308 1.6×	32	2.1k
Dale N. Gerding United States	15	1.4k 1.3×	936 1.0×	303 0.8×	155 0.8×	121 0.6×	17	1.7k
Sarah E. Turbett United States	10	703 0.6×	340 0.4×	119 0.3×	573 2.8×	203 1.0×	43	1.2k

Countries citing papers authored by Karl Weiss

Since Specialization

Citations

This map shows the geographic impact of Karl Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Weiss more than expected).

Fields of papers citing papers by Karl Weiss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Weiss. The network helps show where Karl Weiss may publish in the future.

Co-authorship network of co-authors of Karl Weiss

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Weiss. A scholar is included among the top collaborators of Karl Weiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Weiss. Karl Weiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mohr, Isabelle, Alexander Olkus, Matthias Lang, et al.. (2025). A comparative analysis in monitoring 24-hour urinary copper in wilson disease: sampling on or off treatment?. Orphanet Journal of Rare Diseases. 20(1). 33–33.

Mohr, Isabelle, et al.. (2024). Clinical experience on switching trientine tetrahydrochloride to trientine dihydrochloride in Wilson disease patients. JIMD Reports. 65(6). 406–416. 1 indexed citations

Park, Hyejin, Bluma Brenner, Ruxandra-Ilinca Ibanescu, et al.. (2021). Phylogenetic Clustering among Asylum Seekers with New HIV-1 Diagnoses in Montreal, QC, Canada. Viruses. 13(4). 601–601. 3 indexed citations

Al‐Saeedi, Mohammed, Omid Ghamarnejad, Elias Khajeh, et al.. (2020). Pringle Maneuver in Extended Liver Resection: A propensity score analysis. Scientific Reports. 10(1). 8847–8847. 19 indexed citations

Mohr, Isabelle & Karl Weiss. (2019). Biochemical markers for the diagnosis and monitoring of Wilson Disease. PubMed. 40(2). 59–77. 49 indexed citations

Wuytack, Francesca, Vittoria Lutje, Janus Christian Jakobsen, et al.. (2018). Sexual transmission of Hepatitis C Virus infection in a heterosexual population: A systematic review. SHILAP Revista de lepidopterología. 1. 10–10. 2 indexed citations

Busch, Cornelius, Benedikt Hermann Siegler, Christoph Lichtenstern, et al.. (2018). Risk factors for early viral infections after liver transplantation. Langenbeck s Archives of Surgery. 403(4). 509–519. 9 indexed citations

Al‐Saeedi, Mohammed, Pascal Probst, Elias Khajeh, et al.. (2018). Meta-analysis of patient survival and rate of alcohol relapse in liver-transplanted patients for acute alcoholic hepatitis. Langenbeck s Archives of Surgery. 403(7). 825–836. 11 indexed citations

Simor, Andrew E., Linda Pelude, George R. Golding, et al.. (2016). Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012. Infection Control and Hospital Epidemiology. 37(4). 390–397. 25 indexed citations

10.

Simor, Andrew E., Victoria Williams, Allison McGeer, et al.. (2013). Prevalence of Colonization and Infection with Methicillin-ResistantStaphylococcus aureusand Vancomycin-ResistantEnterococcusand ofClostridium difficileInfection in Canadian Hospitals. Infection Control and Hospital Epidemiology. 34(7). 687–693. 34 indexed citations

11.

Crook, Derrick W., A. Sarah Walker, Yin Kean, et al.. (2012). Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials. Clinical Infectious Diseases. 55(suppl_2). S93–S103. 197 indexed citations

12.

Cornely, Oliver A., Derrick W. Crook, Roberto Esposito, et al.. (2012). Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. The Lancet Infectious Diseases. 12(4). 281–289. 560 indexed citations breakdown →

13.

Weiss, Karl. (2009). Clostridium difficile and fluoroquinolones: is there a link?. International Journal of Antimicrobial Agents. 33. S29–S32. 17 indexed citations

14.

Weiss, Karl, Annie Boisvert, Miguel Chagnon, et al.. (2009). Multipronged Intervention Strategy to Control an Outbreak of Clostridium difficile Infection (CDI) and Its Impact on the Rates of CDI from 2002 to 2007. Infection Control and Hospital Epidemiology. 30(2). 156–162. 56 indexed citations

15.

Weiss, Karl. (2008). Toxin-binding treatment for Clostridium difficile: a review including reports of studies with tolevamer. International Journal of Antimicrobial Agents. 33(1). 4–7. 59 indexed citations

16.

Weiss, Karl, et al.. (2007). Clostridium difficile-associated diarrhoea rates and global antibiotic consumption in five Quebec institutions from 2001 to 2004. International Journal of Antimicrobial Agents. 30(4). 309–314. 14 indexed citations

17.

Boily-Larouche, Geneviève, et al.. (2005). Genetic analysis of pbp2x in clinical Streptococcus pneumoniae isolates in Quebec, Canada. Journal of Antimicrobial Chemotherapy. 55(6). 832–839. 20 indexed citations

18.

Baril, Jean-Guy, Roger LeBlanc, François Laplante, et al.. (2005). HIV‐associated Lipodystrophy Syndrome: A Review of Clinical Aspects. Canadian Journal of Infectious Diseases and Medical Microbiology. 16(4). 233–243. 51 indexed citations

19.

Laverdière, Michél, et al.. (1998). Primary renal mucormycosis. Urology. 52(5). 900–903. 22 indexed citations

20.

Weiss, Karl, et al.. (1994). Hepatitis E: A Newcomer to the Hepatitis Alphabet – Case Report and Review of the Literature. Canadian Journal of Infectious Diseases and Medical Microbiology. 6(1). 34–37. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact